APA (7th ed.) Citation

HN, G., XS, W., ZJ, P., HM, L., KQ, C., MX, T., . . . C, Z. (2026). Emerging small-molecule AKR1C3 inhibitors development for cancer therapy: Progress from 2021 to 2025. European journal of medicinal chemistry, 304, 118490. https://doi.org/10.1016/j.ejmech.2025.118490

Chicago Style (17th ed.) Citation

HN, Gao, et al. "Emerging Small-molecule AKR1C3 Inhibitors Development for Cancer Therapy: Progress from 2021 to 2025." European Journal of Medicinal Chemistry 304 (2026): 118490. https://doi.org/10.1016/j.ejmech.2025.118490.

MLA (9th ed.) Citation

HN, Gao, et al. "Emerging Small-molecule AKR1C3 Inhibitors Development for Cancer Therapy: Progress from 2021 to 2025." European Journal of Medicinal Chemistry, vol. 304, 2026, p. 118490, https://doi.org/10.1016/j.ejmech.2025.118490.